Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...

Eric Schmidt’s AI predictions reveal a future of innovation, risks, and ethical dilemmas. Are we ready for the rise of ...

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

Demis Hassabis said that AI could lead to ‘radical abundance,’ while also posing various risks in the medical sector.

At the heart of Demis Hassabis’ vision is the revolutionary impact AI could have on healthcare, particularly in accelerating ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

AI’s Bold Future in Healthcare Demis Hassabis, CEO and co-founder of Google DeepMind, has made a sweeping prediction: AI ...

which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday. Google ...

Google-Backed AI Drug Discovery Startup Raises $600 Million (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...